ELOXX PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 23.72K shares.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 19.97K shares, a 269.67% increase year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 23.49K shares, a 36.50% increase from fiscal 2020.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 17.21K shares, a 85.21% decline from fiscal 2019.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 116.33K shares, a 91.28% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: S-1 6 month − S-1/A 3 month · filed 2026-09-11 | |
| 2026-03-31 | 23.72K shares S-1/A · filed 2026-06-04 | |
| 2025-12-31 | 18.25K shares S-1 · filed 2026-09-11 | |
| 2022-12-31 | 0.00 shares 10-K · filed 2023-03-31 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 23.49K shares 10-K · filed 2022-03-30 |
| 2021-09-30 | 19.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | |
| 2020-12-31 | 1.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | 17.21K shares 10-K · filed 2021-03-12 |
| 2020-09-30 | 5.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | 41.04K shares derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | 65.17K shares derived: sum of 4 quarters · filed 2020-08-07 |
| 2020-03-31 | 10.64K shares 10-Q · filed 2020-05-08 | 101.96K shares derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-12-31 | 25.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | 116.33K shares 10-K · filed 2020-03-06 |
| 2019-09-30 | 29.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 503.32K shares derived: sum of 4 quarters · filed 2019-11-06 |
| 2019-06-30 | 36.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 729.18K shares derived: sum of 4 quarters · filed 2019-08-07 |
| 2019-03-31 | 25.00K shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 412.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | 1.33M shares 10-K · filed 2019-03-14 |
| 2018-09-30 | 255.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | |
| 2017-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | 0.00 shares 10-K · filed 2017-10-13 |
| 2017-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-22 | 0.00 shares derived: sum of 4 quarters · filed 2017-10-13 |
| 2016-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | 0.00 shares derived: sum of 4 quarters · filed 2017-10-13 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2017-10-13 |
| 2016-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | 0.00 shares 10-K · filed 2017-10-13 |
| 2016-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | 0.00 shares derived: sum of 4 quarters · filed 2017-10-13 |
| 2015-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | 0.00 shares derived: sum of 4 quarters · filed 2017-10-13 |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-16 | 0.00 shares derived: sum of 4 quarters · filed 2017-10-13 |
| 2015-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | 0.00 shares 10-K · filed 2017-10-13 |
| 2015-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-14 | 0.00 shares derived: sum of 4 quarters · filed 2016-10-13 |
| 2014-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | 0.00 shares derived: sum of 4 quarters · filed 2016-10-13 |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2016-10-13 |
| 2014-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | 0.00 shares 10-K · filed 2016-10-13 |
| 2014-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | 0.00 shares derived: sum of 4 quarters · filed 2015-10-09 |
| 2013-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | 0.00 shares derived: sum of 4 quarters · filed 2015-10-09 |
| 2013-09-30 | 0.00 shares 10-Q · filed 2013-11-14 | |
| 2013-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-09 | 0.00 shares 10-K · filed 2015-10-09 |
| 2013-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | |
| 2012-06-30 | 0.00 shares 10-K · filed 2014-09-29 | |
| 2011-06-30 | 0.00 shares 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |